1. Home
  2. LAES vs PRME Comparison

LAES vs PRME Comparison

Compare LAES & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$2.73

Market Cap

606.5M

Sector

Technology

ML Signal

HOLD

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.68

Market Cap

666.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAES
PRME
Founded
2022
2019
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
606.5M
666.1M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
LAES
PRME
Price
$2.73
$3.68
Analyst Decision
Buy
Buy
Analyst Count
1
6
Target Price
$4.00
$7.56
AVG Volume (30 Days)
12.8M
1.8M
Earning Date
03-31-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.18
EPS
N/A
N/A
Revenue
N/A
$4,632,000.00
Revenue This Year
$93.36
$7.06
Revenue Next Year
$43.06
$47.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
55.28
52 Week Low
$1.99
$1.11
52 Week High
$8.71
$6.94

Technical Indicators

Market Signals
Indicator
LAES
PRME
Relative Strength Index (RSI) 46.75 50.15
Support Level $2.54 $3.17
Resistance Level $2.88 $3.94
Average True Range (ATR) 0.22 0.22
MACD 0.08 0.01
Stochastic Oscillator 56.98 55.34

Price Performance

Historical Comparison
LAES
PRME

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: